Laura L Daniel Selected Research

Myocardial Infarction

1/2016	Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
12/2014	Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction.
1/2013	Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura L Daniel Research Topics

Disease

4	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 04/2012
3	Myocardial Infarction 01/2016 - 01/2013
3	Infarction (Infarctions) 01/2016 - 01/2013
2	Fibrosis (Cirrhosis) 01/2013 - 04/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Long QT Syndrome 01/2022
1	Left Ventricular Dysfunction 01/2016
1	Hypertrophy 04/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2012
4	Phosphotransferases (Kinase)IBA 01/2016 - 04/2012
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022
1	2-mercaptopurineIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Sodium Channels (Sodium Channel)IBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2013
1	Superoxide DismutaseIBA 01/2013
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Connective Tissue Growth FactorIBA 04/2012
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2012
1	Atrial Natriuretic Factor (ANF)IBA 04/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 04/2012
1	Plasminogen Activator Inhibitor 1IBA 04/2012